Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
…, AP Meert, A Scherpereel, AB Cortot, I CsToth… - Lung Cancer, 2013 - Elsevier
Clinical variables, like stage and performance status (PS), have predictive and prognostic
values in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy, …
values in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy, …
[HTML][HTML] Prospective validation obtained in a similar group of patients and with similar high throughput biological tests failed to confirm signatures for prediction of …
…, L Ameye, JJ Lafitte, B Colinet, A Cortot, I CsToth… - Frontiers in …, 2015 - frontiersin.org
Aim: Cisplatin doublets are standard 1st line treatment for advanced non-small cell lung cancer
(NSCLC), without accurate predictor for response and survival, but important toxicity. Our …
(NSCLC), without accurate predictor for response and survival, but important toxicity. Our …
C-erbB-3 expression in non-small cell lung cancer (NSCLC) patients treated by Erlotinib
I CsTOTH, G Anthoine, T Berghmans… - Anticancer …, 2011 - ar.iiarjournals.org
Background: The clinical impact of c-erbB-3 has seldom been assessed in patients with non
small cell lung cancer (NSCLC). Patients and Methods: Forty-three NSCLC patients treated …
small cell lung cancer (NSCLC). Patients and Methods: Forty-three NSCLC patients treated …
Identification of occupational exposure in thoracic oncology: A Belgian experience
I Morelle, T Berghmans, I CsToth… - Revue des Maladies …, 2013 - europepmc.org
Results Among 81 occupational histories, 28 patients (35%) were found to have been
definitely or probably exposed to one or more lung carcinogens (known or suspected). These …
definitely or probably exposed to one or more lung carcinogens (known or suspected). These …
Renal cysts-A novel complication of crizotinib treatment for lung cancer
I CsToth, AP Meert, JP Sculier… - Revue des Maladies …, 2015 - europepmc.org
We report the case of a woman with an ALK positive lung adenocarcinoma, who developed
bilateral complex renal cysts 17 months after the introduction of treatment with crizotinib. …
bilateral complex renal cysts 17 months after the introduction of treatment with crizotinib. …
An atypical presentation of bronchial adenocarcinoma
I Cstoth, T Berghmans, F Feoli… - Revue Medicale de …, 2013 - europepmc.org
Currently, adenocarcinoma represents 41% of primary lung cancers in women and 34% in
men. Thyroid metastases of lung cancer are rare and usually asymptomatic. We report the …
men. Thyroid metastases of lung cancer are rare and usually asymptomatic. We report the …
A mRNA signature predicts outcome of patients (pts) with advanced non small cell lung cancer (NSCLC) treated with cisplatin (C) and vinorelbine (V): A ELCWP …
…, A Scherpereel, A Cortot, C Mascaux, I CsToth… - 2012 - Eur Respiratory Soc
Background: C-based doublets are standard 1 st line treatment for advanced NSCLC, without
good predictor for response and survival, and important toxicity. Our aim is to identify a …
good predictor for response and survival, and important toxicity. Our aim is to identify a …
[HTML][HTML] Identification of Microrna (MIRNA) Signatures for Response and Survival in Non-Small Cell Lung Cancer (NSCLC) Patients (PTS) Treated with Cisplatin …
I Cstoth, T Berghmans, L Willems, M Paesmans… - Annals of …, 2012 - Elsevier
Background Clinical variables, like stage and performance status (PS), have predictive and
prognostic values in advanced NSCLC pts treated with chemotherapy, but not on an …
prognostic values in advanced NSCLC pts treated with chemotherapy, but not on an …
Identification of a microRNA (miRNA) based signature for survival in advanced non-small cell lung cancer (NSCLC) patients (pts) treated with cisplatin-vinorelbine: A …
…, L Ameye, JJ Lafitte, AP Meert, A Scherpereel, I CsToth… - 2012 - ascopubs.org
e18006 Background: Main prognostic factors for survival in NSCLC pts are stage and performance
status (PS) while sex, histology and others are reported. However, these variables do …
status (PS) while sex, histology and others are reported. However, these variables do …
Recent progress on laser driven accelerators and applications
WP Leemans, CGR GEDDES… - Nuclear Engineering …, 2005 - koreascience.kr
Laser driven accelerators promise to provide an alternative to conventional accelerator
technology. They rely on the excitation of large amplitude density waves in a plasma by the …
technology. They rely on the excitation of large amplitude density waves in a plasma by the …